Wegovy (semaglutide) is a prescription glucagon-like peptide-1 (GLP-1) medication approved by the Food and Drug Administration (FDA) to reduce excess body weight and maintain weight reduction in people ages 12 and older with a diagnosis of obesity or in adults who are overweight with a weight-related health condition
Eli Lilly said the result of its fourth attempt to have Mounjaro PBS-listed is likely to impede future submissions for the drugs other indications
In a randomized trial of semaglutide 2.4 mg vs placebo for 1 year, 529 participants with HFpEF with a BMI of 30 kg/m2, there was a very large reduction in symptoms, improvement in exercise function in the GLP-1 drug assigned group
Smart Fats That Do More Than Satisfy Healthy fats help you feel full longer and improve nutrient absorptionkey when your portion sizes shrink
Pairing L-carnitine with a calorie-controlled diet and a metabolism support supplement like Garcinia Cambogia can accelerate results further
Taken together, our findings validate GSTO1 as an important drug target for cancer therapeutics
